Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Taelman VF, Radojewski P, Marincek N, Ben-Shlomo A, Grotzky A, Olariu CI, et al
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist that has not received MHRA or EMA approval and holds no UK marketing authorisation
Shaking the vial instead of gentle swirling damages peptide structure
Las limitaciones incluyen que, aunque todos los usuarios de agonistas de GLP-1 tenan antecedentes de obesidad sin diabetes, no se sabe si todos los agonistas de GLP-1 se usaron para perder peso
Dosage and forms According to the prescribing information, Zepbound is available in the following dosages: 2.5 mg per single-use pen 5 mg per single-use pen 7.5 mg per single-use pen 10 mg per single-use pen 12.5 mg per single-use pen 15 mg per single-use pen Each Zepbound pen is for single use
US$ 21.34
US$ 22.45
US$ 25.79
US$ 21.00
US$ 22.54
US$ 24.53
